<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03324984</url>
  </required_header>
  <id_info>
    <org_study_id>2017-8414</org_study_id>
    <nct_id>NCT03324984</nct_id>
  </id_info>
  <brief_title>2-Chloroprocaine(PF) vs. Bupivacaine Spinals</brief_title>
  <official_title>Comparison of 2- Chloroprocaine vs. Hyperbaric Bupivacaine Spinals in Patients Undergoing Hemorrhoidectomies in an Ambulatory Surgery Center: A Double-Blind Randomized Controlled Pilot Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Montefiore Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The use of 2-Chloroprocaine (PF) spinal anesthesia will reduce the recovery times and
      discharge time of patients undergoing hemorrhoidectomies as compared to 0.75% bupivacaine
      spinal. The primary objective is to compare the recovery times (return of motor and sensory
      function) and discharge time (voiding time) between 2-Chloroprocaine and 0.75% bupivacaine
      spinal anesthesia for hemorrhoidectomies. This is a randomized, prospective study assigning
      patients to either 2-Chloroprocaine (PF) or 0.75% bupivacaine spinal anesthesia group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The use of 2-Chloroprocaine (PF) spinal anesthesia will reduce the recovery times and
      discharge time of patients undergoing hemorrhoidectomies as compared to 0.75% bupivacaine
      spinal. The primary objective is to compare the recovery times (return of motor and sensory
      function) and discharge time (voiding time) between 2-Chloroprocaine and 0.75% bupivacaine
      spinal anesthesia for hemorrhoidectomies. This is a randomized, prospective study assigning
      patients to either 2-Chloroprocaine (PF) or 0.75% bupivacaine spinal anesthesia group.
      Consents for participation in the study will be obtained during the patients' preoperative
      anesthesia evaluation. There will be no change in the primary anesthetic technique (spinal
      anesthesia), since these patients routinely get spinal anesthesia for hemorrhoidectomies,
      however there would be a change in type of local anesthetic administration. On the day of
      surgery, consented patients will be randomized to one of the two groups. Both the patients
      and the researcher who recruited the patients and collected the data will be blinded.
      (Research assistant will hand an enclosed envelop to the anesthesiologists performing the
      spinal anesthesia with the name of local anesthetic to use) Postoperatively, the PACU nurse
      will be ask to document return of motor and sensory function in addition to voiding time. At
      the time of voiding, the nurse will be asked to inform an anesthesiologist (not involved in
      the case) for a postoperative evaluation and a discharge note. However, if the patient cannot
      void once there are able to ambulate, then they stay in PACU until they are the last patient
      in the unit. If still unable to void, the surgeon will be informed and an ultrasound bladder
      scan will be used to determine the volume of urine and the patient will be straight cath. The
      patient will be sent home and informed if he or she cannot void by the next day, then they
      should call the surgeon's office to notify them and go to the emergency room.

      For postoperative data collection, the routine 24hr postoperative phone calls in which nurses
      make to patients will be utilize, however two additional questions will be asked, 1. Presence
      of nerve pain in the buttocks and thighs shooting down their legs unilaterally or
      bilaterally, 2. Inability to void, pass flatus or defecate. If any of the symptoms are
      present, then the nurse will inform an anesthesiologist (not involved in the case) whom will
      give the patient a call and advise them on treatment protocol. The research assistant will
      then be informed by the anesthesiologist who made the phone call.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    IND required for IRB approval
  </why_stopped>
  <start_date type="Anticipated">November 20, 2017</start_date>
  <completion_date type="Anticipated">November 20, 2019</completion_date>
  <primary_completion_date type="Anticipated">November 20, 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>recovery time</measure>
    <time_frame>Up to 100 minutes</time_frame>
    <description>recovery time (return of motor and sensory function)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>discharge time (voiding time)</measure>
    <time_frame>Up to 160 minutes</time_frame>
    <description>discharge time (voiding time)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>evidence of hypotension</measure>
    <time_frame>0 minutes to 5 minutes of spinal anesthesia</time_frame>
    <description>evidence of hypotension during the case</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>evidence of TNS</measure>
    <time_frame>24 hours post operation</time_frame>
    <description>evidence of TNS (transient neurologic symptoms) 24hr after procedure.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Return of Motor and Sensory Blockade</condition>
  <condition>Anesthesia, Spinal</condition>
  <condition>Decrease Discharge Time Status Post Hemmoriodectomy</condition>
  <arm_group>
    <arm_group_label>2-Chloroprocaine (PF)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2-Chloroprocaine is an ester-linked local anesthetic with the shortest duration of action of all local anesthetics.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.75% bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.75% bupivacaine is a amino-amide anesthetic local anesthetic. It is hyperbaric in nature due to addition of dextrose.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>2-chloroprocaine</intervention_name>
    <description>Since 2004, 2-Chloroprocaine-PF has been used off label for spinal anesthesia and there have been very few incidence of TNS noted. The concern prior to 2004, was the the vials of Chloroprocaine had preservative sodium metabisulfite and methylparaben in them so they were not used for spinal because of incidence of transient neurologic symptoms (TNS).</description>
    <arm_group_label>2-Chloroprocaine (PF)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.75% bupivacaine</intervention_name>
    <description>Bupivacaine is used on label</description>
    <arm_group_label>0.75% bupivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient undergoing Hemorrhoidectomies

          -  Age 18 and above

          -  ASA, I-III

        Exclusion Criteria:

          -  Patient refusal

          -  Inability to understand and sign consent

          -  Allergic reaction to bupivacaine or other local anesthetics

          -  Coagulopathy (INR &gt; 1.5)

          -  Use of anticoagulant drugs (Plavix, Coumadin)

          -  Thrombocytopenia (Platelets &lt; 100,000)

          -  Infection at the site

          -  Increased intracranial pressure

          -  Unstable spine, Spine abnormalities
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Iyabo Muse, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montefiore Medicial Center</affiliation>
  </overall_official>
  <reference>
    <citation>Apfelbaum JL, Walawander CA, Grasela TH, Wise P, McLeskey C, Roizen MF, Wetchler BV, Korttila K. Eliminating intensive postoperative care in same-day surgery patients using short-acting anesthetics. Anesthesiology. 2002 Jul;97(1):66-74.</citation>
    <PMID>12131105</PMID>
  </reference>
  <reference>
    <citation>Liu SS, Strodtbeck WM, Richman JM, Wu CL. A comparison of regional versus general anesthesia for ambulatory anesthesia: a meta-analysis of randomized controlled trials. Anesth Analg. 2005 Dec;101(6):1634-42.</citation>
    <PMID>16301234</PMID>
  </reference>
  <reference>
    <citation>FÃ¶rster JG. Short-acting spinal anesthesia in the ambulatory setting. Curr Opin Anaesthesiol. 2014 Dec;27(6):597-604. doi: 10.1097/ACO.0000000000000126. Review.</citation>
    <PMID>25211156</PMID>
  </reference>
  <reference>
    <citation>Pollock JE. Transient neurologic symptoms: etiology, risk factors, and management. Reg Anesth Pain Med. 2002 Nov-Dec;27(6):581-6. Review. Erratum in: Reg Anesth Pain Med. 2003 May-Jun;28(3):257.</citation>
    <PMID>12430108</PMID>
  </reference>
  <reference>
    <citation>Fanelli A, Ghisi D, Allegri M. Is spinal anaesthesia a suitable technique for ultra-short outpatient procedures? Acta Biomed. 2013 Jun 1;84(1):76-80.</citation>
    <PMID>24189768</PMID>
  </reference>
  <reference>
    <citation>Smith KN, Kopacz DJ, McDonald SB. Spinal 2-chloroprocaine: a dose-ranging study and the effect of added epinephrine. Anesth Analg. 2004 Jan;98(1):81-8, table of contents.</citation>
    <PMID>14693591</PMID>
  </reference>
  <reference>
    <citation>Vath JS, Kopacz DJ. Spinal 2-chloroprocaine: the effect of added fentanyl. Anesth Analg. 2004 Jan;98(1):89-94, table of contents.</citation>
    <PMID>14693593</PMID>
  </reference>
  <reference>
    <citation>Kouri ME, Kopacz DJ. Spinal 2-chloroprocaine: a comparison with lidocaine in volunteers. Anesth Analg. 2004 Jan;98(1):75-80, table of contents.</citation>
    <PMID>14693590</PMID>
  </reference>
  <reference>
    <citation>Yoos JR, Kopacz DJ. Spinal 2-chloroprocaine for surgery: an initial 10-month experience. Anesth Analg. 2005 Feb;100(2):553-8.</citation>
    <PMID>15673893</PMID>
  </reference>
  <reference>
    <citation>Hejtmanek MR, Pollock JE. Chloroprocaine for spinal anesthesia: a retrospective analysis. Acta Anaesthesiol Scand. 2011 Mar;55(3):267-72. doi: 10.1111/j.1399-6576.2010.02371.x.</citation>
    <PMID>21288208</PMID>
  </reference>
  <reference>
    <citation>Pavlin DJ, Pavlin EG, Fitzgibbon DR, Koerschgen ME, Plitt TM. Management of bladder function after outpatient surgery. Anesthesiology. 1999 Jul;91(1):42-50.</citation>
    <PMID>10422927</PMID>
  </reference>
  <reference>
    <citation>Mulroy MF. Outpatients do not need to void after short neuraxial blocks. Anesthesiology. 2009 Dec;111(6):1388; author reply 1389. doi: 10.1097/ALN.0b013e3181bfa8d3.</citation>
    <PMID>19934900</PMID>
  </reference>
  <reference>
    <citation>Lacasse MA, Roy JD, Forget J, Vandenbroucke F, Seal RF, Beaulieu D, McCormack M, Massicotte L. Comparison of bupivacaine and 2-chloroprocaine for spinal anesthesia for outpatient surgery: a double-blind randomized trial. Can J Anaesth. 2011 Apr;58(4):384-91. doi: 10.1007/s12630-010-9450-x. Epub 2011 Jan 4.</citation>
    <PMID>21203878</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 25, 2017</study_first_submitted>
  <study_first_submitted_qc>October 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2017</study_first_posted>
  <last_update_submitted>March 22, 2018</last_update_submitted>
  <last_update_submitted_qc>March 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Montefiore Medical Center</investigator_affiliation>
    <investigator_full_name>Iyabo Muse</investigator_full_name>
    <investigator_title>Assistant Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>Spinal anesthesia</keyword>
  <keyword>Pain</keyword>
  <keyword>Chloroprocaine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Chloroprocaine</mesh_term>
    <mesh_term>Procaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

